$DXCM
DEXCOM INC Stock $dxcm

$dxcm Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-K Financial Statement

#000109355719000041 Filed on February 21, 2019

Income Statement

Concept	2018 Q4	2017 Q4	2017 Q3
Revenue	$338.0M	$221.0M	$184.6M
YoY Change	52.94%	29.09%	24.23%
Cost Of Revenue	$115.2M	$67.50M	$57.60M
YoY Change	70.67%	23.85%	21.26%
Gross Profit	$222.8M	$153.5M	$127.0M
YoY Change	45.15%	31.53%	25.62%
Gross Profit Margin	65.92%	69.46%	68.8%
Selling, General & Admin	$112.1M	$92.80M	$84.20M
YoY Change	20.8%	17.32%	11.23%
% of Gross Profit	50.31%	60.46%	66.3%
Research & Development	$275.3M	$48.70M	$43.30M
YoY Change	465.3%	11.44%	-1.37%
% of Gross Profit	123.56%	31.73%	34.09%
Depreciation & Amortization	$8.600M	$16.10M	$4.300M
YoY Change	-46.58%	347.22%	4.88%
% of Gross Profit	3.86%	10.49%	3.39%
Operating Expenses	$387.4M	$141.5M	$127.5M
YoY Change	173.78%	15.23%	6.61%
Operating Profit	-$164.6M	$12.00M	-$500.0K
YoY Change	-1471.67%	-296.72%	-97.3%
Interest Expense	-$16.90M	-$3.300M	$4.500M
YoY Change	412.12%	1550.0%	2150.0%
% of Operating Profit		-27.5%
Other Income/Expense, Net	$4.600M	-$100.0K	$1.300M
YoY Change	-4700.0%	-85.71%
Pretax Income	-$176.9M	$12.40M	-$2.500M
YoY Change	-1526.61%	-277.14%	-86.56%
Income Tax	$3.200M	$1.600M	-$500.0K
% Of Pretax Income		12.9%
Net Earnings	-$179.7M	-$9.400M	-$2.000M
YoY Change	1811.7%	27.03%	-89.36%
Net Earnings / Revenue	-53.17%	-4.25%	-1.08%
Basic Earnings Per Share	-$2.03	-$0.11	-$0.02
Diluted Earnings Per Share	-$2.03	-$0.11	-$0.02
COMMON SHARES
Basic Shares Outstanding	88.84M shares	86.90M shares	86.70M shares
Diluted Shares Outstanding			86.70M shares

Balance Sheet

Concept	2018 Q4	2017 Q4	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.230B	$548.6M	$525.8M
YoY Change	124.15%	343.49%	313.04%
Cash & Equivalents	$1.137B	$441.5M	$402.1M
Short-Term Investments	$92.70M	$107.1M	$123.7M
Other Short-Term Assets	$16.50M	$16.60M	$13.30M
YoY Change	-0.6%	80.43%	35.71%
Inventory	$70.70M	$45.20M	$43.30M
Prepaid Expenses
Receivables	$226.7M	$134.3M	$110.5M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.700B	$744.7M	$692.9M
YoY Change	128.21%	165.96%	167.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$183.1M	$145.6M	$136.1M
YoY Change	25.76%	33.09%	53.96%
Goodwill	$18.70M	$12.10M	$12.00M
YoY Change	54.55%	7.08%	1.69%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$14.70M	$1.700M	$1.900M
YoY Change	764.71%	-19.05%	26.67%
Total Long-Term Assets	$216.5M	$159.4M	$150.0M
YoY Change	35.82%	29.8%	45.21%
TOTAL ASSETS
Total Short-Term Assets	$1.700B	$744.7M	$692.9M
Total Long-Term Assets	$216.5M	$159.4M	$150.0M
Total Assets	$1.916B	$904.1M	$842.9M
YoY Change	111.92%	124.45%	132.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$75.50M	$46.70M	$23.30M
YoY Change	61.67%	90.61%	-11.41%
Accrued Expenses	$144.0M	$89.00M	$92.60M
YoY Change	61.8%	15.58%	56.16%
Deferred Revenue	$2.900M	$3.200M
YoY Change	-9.38%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$222.4M	$138.9M	$118.2M
YoY Change	60.12%	35.64%	37.28%
LONG-TERM LIABILITIES
Long-Term Debt	$1.018B	$334.3M	$330.7M
YoY Change	204.4%
Other Long-Term Liabilities	$20.00M	$18.20M	$16.70M
YoY Change	9.89%	9.64%	19.29%
Total Long-Term Liabilities	$20.00M	$18.20M	$16.70M
YoY Change	9.89%	9.64%	19.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$222.4M	$138.9M	$118.2M
Total Long-Term Liabilities	$20.00M	$18.20M	$16.70M
Total Liabilities	$1.253B	$484.7M	$458.9M
YoY Change	158.45%	307.31%	358.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$798.9M	-$671.8M	-$662.4M
YoY Change	18.92%	8.18%	7.95%
Common Stock	$1.561B	$1.094B	$1.049B
YoY Change	42.69%	20.76%	19.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$100.0M	$0.00
YoY Change
Treasury Stock Shares	800.0K shares	0.000 shares
Shareholders Equity	$663.3M	$419.4M	$384.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.916B	$904.1M	$842.9M
YoY Change	111.92%	124.45%	132.91%

Cashflow Statement

Concept	2018 Q4	2017 Q4	2017 Q3
OPERATING ACTIVITIES
Net Income	-$179.7M	-$9.400M	-$2.000M
YoY Change	1811.7%	27.03%	-89.36%
Depreciation, Depletion And Amortization	$8.600M	$16.10M	$4.300M
YoY Change	-46.58%	347.22%	4.88%
Cash From Operating Activities	$33.70M	$41.20M	$36.20M
YoY Change	-18.2%	209.77%	57.39%
INVESTING ACTIVITIES
Capital Expenditures	-$17.70M	-$17.60M	-$13.50M
YoY Change	0.57%	0.0%	-16.15%
Acquisitions
YoY Change
Other Investing Activities	$48.60M	$16.50M	-$23.10M
YoY Change	194.55%	5400.0%	1258.82%
Cash From Investing Activities	$30.90M	-$1.100M	-$36.60M
YoY Change	-2909.09%	-93.64%	105.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	701.6M	100.0K	4.300M
YoY Change	701500.0%	-80.0%	-15.69%
NET CHANGE
Cash From Operating Activities	33.70M	41.20M	36.20M
Cash From Investing Activities	30.90M	-1.100M	-36.60M
Cash From Financing Activities	701.6M	100.0K	4.300M
Net Change In Cash	766.2M	40.20M	3.900M
YoY Change	1805.97%	-1248.57%	-62.14%
FREE CASH FLOW
Cash From Operating Activities	$33.70M	$41.20M	$36.20M
Capital Expenditures	-$17.70M	-$17.60M	-$13.50M
Free Cash Flow	$51.40M	$58.80M	$49.70M
YoY Change	-12.59%	90.29%	27.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Document Type DocumentType	10-K
CY2018	dei	Entity Central Index Key EntityCentralIndexKey	0001093557
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	90001767	shares
CY2018	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2018	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q2	dei	Entity Public Float EntityPublicFloat	8300000000	USD
CY2018	dei	Entity Registrant Name EntityRegistrantName	DEXCOM INC
CY2018	dei	Entity Shell Company EntityShellCompany	false
CY2018	dei	Entity Small Business EntitySmallBusiness	false
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2018	dei	Trading Symbol TradingSymbol	DXCM
CY2017Q4	dxcm	Accrued Tax Audit And Legal Fees AccruedTaxAuditAndLegalFees	7100000	USD
CY2018Q4	dxcm	Accrued Tax Audit And Legal Fees AccruedTaxAuditAndLegalFees	11700000	USD
CY2018	dxcm	Amortization Periodfor Incentive Compensation Costs AmortizationPeriodforIncentiveCompensationCosts	P1Y
CY2016	dxcm	Capitalized Costs And Financing Liability CapitalizedCostsAndFinancingLiability	6000000	USD
CY2017	dxcm	Capitalized Costs And Financing Liability CapitalizedCostsAndFinancingLiability	0	USD
CY2018	dxcm	Capitalized Costs And Financing Liability CapitalizedCostsAndFinancingLiability	0	USD
CY2016	dxcm	Collaborative Research And Development Fee CollaborativeResearchAndDevelopmentFee	0	USD
CY2017	dxcm	Collaborative Research And Development Fee CollaborativeResearchAndDevelopmentFee	0	USD
CY2018	dxcm	Collaborative Research And Development Fee CollaborativeResearchAndDevelopmentFee	217700000	USD
CY2018Q4	dxcm	Concentration Risk Percentageof Accounts Receivableattributabletocustomer ConcentrationRiskPercentageofAccountsReceivableattributabletocustomer	0.1
CY2017	dxcm	Cumulative Foreign Deficits CumulativeForeignDeficits	41200000	USD
CY2018	dxcm	Cumulative Foreign Deficits CumulativeForeignDeficits	24600000	USD
CY2018	dxcm	Customer Concentration Number Of Customers CustomerConcentrationNumberOfCustomers	2	customer
CY2017Q4	dxcm	Debt Securities Available For Saleand Equity Securities DebtSecuritiesAvailableForSaleandEquitySecurities	107100000	USD
CY2018Q4	dxcm	Debt Securities Available For Saleand Equity Securities DebtSecuritiesAvailableForSaleandEquitySecurities	248600000	USD
CY2018	dxcm	Debt Securities Available For Saleand Equity Securities Unrealized Gain DebtSecuritiesAvailableForSaleandEquitySecuritiesUnrealizedGain	36000000	USD
CY2018	dxcm	Debt Securities Available For Saleand Equity Securities Unrealized Loss DebtSecuritiesAvailableForSaleandEquitySecuritiesUnrealizedLoss	100000	USD
CY2018Q4	dxcm	Debt Securities Availableforsaleand Equity Securities Amortized Cost DebtSecuritiesAvailableforsaleandEquitySecuritiesAmortizedCost	212700000	USD
CY2017Q4	dxcm	Deferred Tax Assets Liabilities Less Valuation Allowance Net DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet	100000	USD
CY2018Q4	dxcm	Deferred Tax Assets Liabilities Less Valuation Allowance Net DeferredTaxAssetsLiabilitiesLessValuationAllowanceNet	100000	USD
CY2018	dxcm	Deferred Tax Assets Tax Benefits Creditedto Additional Paid In Capital DeferredTaxAssetsTaxBenefitsCreditedtoAdditionalPaidInCapital	56200000	USD
CY2017Q4	dxcm	Deferred Tax Liabilities Convertible Debt Discount DeferredTaxLiabilitiesConvertibleDebtDiscount	15900000	USD
CY2018Q4	dxcm	Deferred Tax Liabilities Convertible Debt Discount DeferredTaxLiabilitiesConvertibleDebtDiscount	100000	USD
CY2016	dxcm	Effective Income Tax Reconciliation Impactof Adoptionof Asu201616 EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616	0	USD
CY2017	dxcm	Effective Income Tax Reconciliation Impactof Adoptionof Asu201616 EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616	0	USD
CY2018	dxcm	Effective Income Tax Reconciliation Impactof Adoptionof Asu201616 EffectiveIncomeTaxReconciliationImpactofAdoptionofASU201616	-13300000	USD
CY2016	dxcm	Effective Income Tax Reconciliation Impactof Tcja EffectiveIncomeTaxReconciliationImpactofTCJA	0	USD
CY2017	dxcm	Effective Income Tax Reconciliation Impactof Tcja EffectiveIncomeTaxReconciliationImpactofTCJA	105700000	USD
CY2018	dxcm	Effective Income Tax Reconciliation Impactof Tcja EffectiveIncomeTaxReconciliationImpactofTCJA	-400000	USD
CY2016	dxcm	Effective Income Tax Reconciliation Permanent Items EffectiveIncomeTaxReconciliationPermanentItems	800000	USD
CY2017	dxcm	Effective Income Tax Reconciliation Permanent Items EffectiveIncomeTaxReconciliationPermanentItems	700000	USD
CY2018	dxcm	Effective Income Tax Reconciliation Permanent Items EffectiveIncomeTaxReconciliationPermanentItems	1300000	USD
CY2016	dxcm	Effective Income Tax Reconciliation Unrecognizedtaxbenefits EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits	27700000	USD
CY2017	dxcm	Effective Income Tax Reconciliation Unrecognizedtaxbenefits EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits	-15400000	USD
CY2018	dxcm	Effective Income Tax Reconciliation Unrecognizedtaxbenefits EffectiveIncomeTaxReconciliationUnrecognizedtaxbenefits	0	USD
CY2018	dxcm	Employee Purchase Price Floor Percentage EmployeePurchasePriceFloorPercentage	0.85
CY2018	dxcm	Employee Stock Purchase Plan Espp Number Of Shares Authorized EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized	1500000	shares
CY2017Q4	dxcm	Employee Stock Purchase Plan Espp Shares In Espp EmployeeStockPurchasePlanEsppSharesInEspp	1300000	shares
CY2018Q4	dxcm	Employee Stock Purchase Plan Espp Shares In Espp EmployeeStockPurchasePlanEsppSharesInEspp	1100000	shares
CY2017Q4	dxcm	Fair Value Assets Level3 Transfers Amount FairValueAssetsLevel3TransfersAmount	0	USD
CY2018Q4	dxcm	Fair Value Assets Level3 Transfers Amount FairValueAssetsLevel3TransfersAmount	0	USD
CY2017Q4	dxcm	Financing Lease Obligation FinancingLeaseObligation	6700000	USD
CY2018Q4	dxcm	Financing Lease Obligation FinancingLeaseObligation	7300000	USD
CY2018	dxcm	In Money Options Maximum Exercise Price InMoneyOptionsMaximumExercisePrice	119.80
CY2016	dxcm	Interestand Other Income Expense InterestandOtherIncomeExpense	-300000	USD
CY2017	dxcm	Interestand Other Income Expense InterestandOtherIncomeExpense	6700000	USD
CY2018	dxcm	Interestand Other Income Expense InterestandOtherIncomeExpense	2400000	USD
CY2018Q4	dxcm	Lineof Credit Facility Maturity Conditional Restrictions Valueof Unrestricted Cashon Hand Threshold LineofCreditFacilityMaturityConditionalRestrictionsValueofUnrestrictedCashonHandThreshold	100000000	USD
CY2018	dxcm	Maturity Threshold Of Investments Classified To Cash Equivalents MaturityThresholdOfInvestmentsClassifiedToCashEquivalents	P90D
CY2018	dxcm	Number Of Purchase Periods Within Offering Period NumberOfPurchasePeriodsWithinOfferingPeriod	2
CY2018	dxcm	Numberof Sales Channels NumberofSalesChannels	2	SalesChannel
CY2018	dxcm	Offering Period Months OfferingPeriodMonths	P12M
CY2018	dxcm	Offering Periods Frequency OfferingPeriodsFrequency	P6M
CY2018	dxcm	Options In Money Number OptionsInMoneyNumber	100000	shares
CY2017Q4	dxcm	Pharmacy Rebates PharmacyRebates	13900000	USD
CY2018Q4	dxcm	Pharmacy Rebates PharmacyRebates	36100000	USD
CY2018	dxcm	Purchase Date Frequency Months PurchaseDateFrequencyMonths	P6M
CY2016	dxcm	Purchase Of Convertible Note Hedge PurchaseOfConvertibleNoteHedge	0	USD
CY2017	dxcm	Purchase Of Convertible Note Hedge PurchaseOfConvertibleNoteHedge	0	USD
CY2018	dxcm	Purchase Of Convertible Note Hedge PurchaseOfConvertibleNoteHedge	-218900000	USD
CY2018	dxcm	Purchase Period Months PurchasePeriodMonths	P6M
CY2016	dxcm	R Dexpensethroughissuanceofcommonstock RDexpensethroughissuanceofcommonstock	0	USD
CY2017	dxcm	R Dexpensethroughissuanceofcommonstock RDexpensethroughissuanceofcommonstock	0	USD
CY2018	dxcm	R Dexpensethroughissuanceofcommonstock RDexpensethroughissuanceofcommonstock	217700000	USD
CY2018	dxcm	Recorded Unconditional Purchase Obligation Due Within One Year Maximum Term RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm	P1Y
CY2016	dxcm	Revenue Percentage RevenuePercentage	1
CY2017	dxcm	Revenue Percentage RevenuePercentage	1
CY2018	dxcm	Revenue Percentage RevenuePercentage	1
CY2018	dxcm	Revenue Recognition Sales Returns Coverage Period RevenueRecognitionSalesReturnsCoveragePeriod	P30D
CY2017	dxcm	Standard Product Warranty Accrual Charges To Costs And Expenses StandardProductWarrantyAccrualChargesToCostsAndExpenses	18400000	USD
CY2018	dxcm	Standard Product Warranty Accrual Charges To Costs And Expenses StandardProductWarrantyAccrualChargesToCostsAndExpenses	17400000	USD
CY2017Q4	dxcm	Stock Options Reserved For Future Grant StockOptionsReservedForFutureGrant	4700000	shares
CY2018Q4	dxcm	Stock Options Reserved For Future Grant StockOptionsReservedForFutureGrant	3200000	shares
CY2018	dxcm	Tax Cutsand Job Actof2017 Change In Tax Rate Deferred Tax Asset Income Tax Expense Benefit TaxCutsandJobActof2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpenseBenefit	-105300000	USD
CY2017	dxcm	Tax Cutsand Jobs Actof2017 Incomplete Accounting Changein Tax Rate Provisional Income Tax Expense Benefit TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpenseBenefit	-105700000	USD
CY2018	dxcm	Tax Cutsand Jobs Actof2017 Incomplete Accounting Changein Tax Rate Provisional Income Tax Expense Benefit TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpenseBenefit	-105700000	USD
CY2017	dxcm	Tax Cutsand Jobs Actof2017 Incomplete Accounting Provisional Income Tax Expense Benefit TaxCutsandJobsActof2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit	0	USD
CY2018	dxcm	Tax Cutsand Jobs Actof2017 Measurement Period Adjustmentincome Tax Expense Benefit TaxCutsandJobsActof2017MeasurementPeriodAdjustmentincomeTaxExpenseBenefit	400000	USD
CY2017	dxcm	Unrecognized Tax Benefits Decrease Resultingfrom Tax Cuts And Jobs Act Of2017 UnrecognizedTaxBenefitsDecreaseResultingfromTaxCutsAndJobsActOf2017	5400000	USD
CY2018	dxcm	Unused Expired Federal Income Tax Credits UnusedExpiredFederalIncomeTaxCredits	2100000	USD
CY2016	dxcm	Valuation Allowances And Reserves Write Offs And Adjustments ValuationAllowancesAndReservesWriteOffsAndAdjustments	-5600000	USD
CY2017	dxcm	Valuation Allowances And Reserves Write Offs And Adjustments ValuationAllowancesAndReservesWriteOffsAndAdjustments	-7000000	USD
CY2018	dxcm	Valuation Allowances And Reserves Write Offs And Adjustments ValuationAllowancesAndReservesWriteOffsAndAdjustments	-8300000	USD
CY2017Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	87200000	USD
CY2018Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	147100000	USD
CY2017Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	46700000	USD
CY2018Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	75500000	USD
CY2017Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	145800000	USD
CY2018Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	233900000	USD
CY2017Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	134300000	USD
CY2018Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	226700000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	134300000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	226700000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	54800000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	79800000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2600000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1500000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1093700000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1560600000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-218900000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	111300000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	106700000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	101900000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	183800000	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	11900000	USD
CY2017Q4	us-gaap	Advertising Expense AdvertisingExpense	21900000	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	25400000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	110800000	USD
CY2017Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	106200000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	101900000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	11500000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	7200000	USD
CY2016	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	100000	USD
CY2017	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	9400000	USD
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	17900000	USD
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7100000	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4400000	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17200000	shares
CY2017Q4	us-gaap	Assets Assets	904100000	USD
CY2018Q4	us-gaap	Assets Assets	1916000000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	744700000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	1699500000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	200000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	100000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	107300000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	210700000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	107100000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	210600000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	92700000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	14400000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	94500000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	441500000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1137000000	USD
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	86100000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94500000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	441500000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1137100000	USD
CY2016	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8400000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	347000000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	695600000	USD
CY2017Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	344600000	USD
CY2018Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	266000000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	9100000	shares
CY2018Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	7100000	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87300000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	91100000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87000000	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	90000000	shares
CY2017Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	100000	USD
CY2018Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	100000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-66300000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-51800000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-123000000	USD
CY2018	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.1
CY2017Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3200000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2900000	USD
CY2018	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1900000	USD
CY2017Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	327600000	USD
CY2018Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1010300000	USD
CY2016	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	194900000	USD
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	226400000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	367700000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2017Q4	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	800000	USD
CY2017Q4	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1500000	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	100000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	900000	USD
CY2017Q4	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1600000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2800000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	100000	USD
CY2017Q4	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	100000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2700000	USD
CY2016	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	0	USD
CY2017	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	0	USD
CY2018	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	80100000	USD
CY2016	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	USD
CY2017	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	USD
CY2018	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	44100000	USD
CY2016	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	0	USD
CY2017	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	0	USD
CY2018	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	36000000	USD
CY2017Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P6M
CY2018Q4	us-gaap	Debt Securities Available For Sale Term DebtSecuritiesAvailableForSaleTerm	P16M
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-100000	USD
CY2017Q4	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1700000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-100000	USD
CY2017Q4	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-200000	USD
CY2017Q4	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2200000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	8700000	USD
CY2018Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	9400000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2017Q4	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-500000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	400000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	162000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	47800000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	59000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	13800000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	12500000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	8400000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	16000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	279600000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	334100000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	16100000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	188700000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	62100000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	20500000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	22500000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	263500000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	330100000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	16000000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3900000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	100000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3800000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2600000	USD
CY2018	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.04
CY2018	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.5
CY2018	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.75
CY2016	us-gaap	Depreciation Depreciation	14400000	USD
CY2017Q4	us-gaap	Depreciation Depreciation	16100000	USD
CY2018	us-gaap	Depreciation Depreciation	28600000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15000000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16100000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29100000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.53
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.03
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.78
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.58
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.44
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	72400000	USD
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	126500000	USD
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.03
CY2016	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	USD
CY2017	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	300000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1800000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	48500000	USD
CY2017Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2018Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2017	us-gaap	Foreign Earnings Repatriated ForeignEarningsRepatriated	0	USD
CY2018	us-gaap	Foreign Earnings Repatriated ForeignEarningsRepatriated	0	USD
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-5400000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	12100000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	18700000	USD
CY2016	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2017	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2018	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2016Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
CY2016	us-gaap	Gross Profit GrossProfit	378400000	USD
CY2017Q1	us-gaap	Gross Profit GrossProfit	94100000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	117500000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	127000000	USD
CY2017Q4	us-gaap	Gross Profit GrossProfit	153500000	USD
CY2017	us-gaap	Gross Profit GrossProfit	492100000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	118900000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	153600000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	168600000	USD
CY2018Q4	us-gaap	Gross Profit GrossProfit	222800000	USD
CY2018	us-gaap	Gross Profit GrossProfit	663900000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-44400000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	12400000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-28300000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-64900000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-48600000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-126500000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-20500000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-61000000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-98200000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-64900000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-48600000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-126500000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	700000	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1600000	USD
CY2018	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	3700000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1600000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	600000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-3000000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-51100000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	56900000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-100000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-100000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	4500000	USD
CY2017	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	5400000	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-22700000	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-17000000	USD
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-26600000	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	4000000	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-10400000	USD
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-5100000	USD
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	USD
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-2200000	USD
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1300000	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1200000	USD
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-700000	USD
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-5500000	USD
CY2016	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	11700000	USD
CY2017	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	13300000	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	11700000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	100000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	1400000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	2300000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	21100000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	21100000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	56200000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	27200000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	31800000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	93200000	USD
CY2016	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	8500000	USD
CY2017	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	14800000	USD
CY2018	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	23800000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9800000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-400000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	25500000	USD
CY2016	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	5000000	USD
CY2017	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	4800000	USD
CY2018	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	800000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3900000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6700000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3000000	USD
CY2016	us-gaap	Interest Expense InterestExpense	700000	USD
CY2017	us-gaap	Interest Expense InterestExpense	12800000	USD
CY2018	us-gaap	Interest Expense InterestExpense	22700000	USD
CY2016	us-gaap	Interest Paid Net InterestPaidNet	100000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	2400000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	3600000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	17000000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	28700000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	45200000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	70700000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	20000000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	30800000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8200000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	11200000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	9000000	USD
CY2017Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	11100000	USD
CY2018	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	12500000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	484700000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	1252700000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	904100000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1916000000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	138900000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	222400000	USD
CY2018Q4	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2018Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	195600000	USD
CY2018Q4	us-gaap	Litigation Reserve LitigationReserve	0	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8100000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	399100000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	710400000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55900000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-144400000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-139800000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	56200000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	92000000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	123200000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-65600000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-41700000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	2900000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-2000000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-9400000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-50200000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-24200000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	30200000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	46600000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-179700000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-127100000	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	10500000	USD
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	6300000	USD
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	10800000	USD
CY2018	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2016	us-gaap	Operating Expenses OperatingExpenses	442300000	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	134500000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	131100000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	127500000	USD
CY2017Q4	us-gaap	Operating Expenses OperatingExpenses	141500000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	534600000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	149600000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	158500000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	154700000	USD
CY2018Q4	us-gaap	Operating Expenses OperatingExpenses	387400000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	850200000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-63900000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-42500000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-186300000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	68800000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	4700000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	6600000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	17300000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	16900000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	8900000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	14400000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10700000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	17000000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1700000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14700000	USD
CY2016	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2017	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-200000	USD
CY2018	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	100000	USD
CY2016	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-700000	USD
CY2017	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1400000	USD
CY2018	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	4000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-700000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1600000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4100000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18200000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	20000000	USD
CY2016	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2200000	USD
CY2017	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-7900000	USD
CY2018	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-4700000	USD
CY2017Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	2800000	USD
CY2018Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	3300000	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	100000000	USD
CY2016	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	39200000	USD
CY2017	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	171800000	USD
CY2018	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	452500000	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-300000	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	11300000	USD
CY2016	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	0	USD
CY2017	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	0	USD
CY2018	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1000000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	55700000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	66000000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	67100000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2018Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16600000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16500000	USD
CY2016	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2017	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	389000000	USD
CY2018	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	836600000	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10400000	USD
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10100000	USD
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10800000	USD
CY2016	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2017	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	183800000	USD
CY2017Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	75000000	USD
CY2016	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2017	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	75000000	USD
CY2018	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2016	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2300000	USD
CY2017	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2018	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1900000	USD
CY2016	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	38700000	USD
CY2017	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	93400000	USD
CY2018	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	392100000	USD
CY2017	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	19400000	USD
CY2018	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	19400000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	200400000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	262900000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	145600000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	183100000	USD
CY2018Q4	us-gaap	Recorded Unconditional Purchase Obligation Due Within One Year RecordedUnconditionalPurchaseObligationDueWithinOneYear	204000000	USD
CY2016	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2017	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	75000000	USD
CY2018	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	156100000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	185400000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	199700000	USD
CY2016Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2017Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2018Q4	us-gaap	Restricted Cash RestrictedCash	100000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-671800000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-798900000	USD
CY2016	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	573300000	USD
CY2017Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	142300000	USD
CY2017Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	170600000	USD
CY2017Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	184600000	USD
CY2017Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	221000000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	718500000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	184400000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	242500000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	266700000	USD
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	338000000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1031600000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	286200000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	349200000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	432800000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	110800000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	106200000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	101900000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2700000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2700000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate	0.10
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	4000000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	100000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	8.02
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	39900000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	21600000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	30000000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.00
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9600000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	400000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	100000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.71
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.02
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.34
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	9600000	USD
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P11M12D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P11M12D
CY2016Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	9800000	USD
CY2017Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8800000	USD
CY2018Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	6800000	USD
CY2016	us-gaap	Stock Issued1 StockIssued1	7200000	USD
CY2017	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2018	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	300000	shares
CY2016	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	7200000	USD
CY2016	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	4400000	USD
CY2017	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	2700000	USD
CY2018	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	1900000	USD
CY2016	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	6000000	USD
CY2017	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	7400000	USD
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	8900000	USD
CY2018	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	217700000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	221200000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	283800000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	419400000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	663300000	USD
CY2018	us-gaap	Tax Credit Carryforward Expiration Date TaxCreditCarryforwardExpirationDate	2020-01-01
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	800000	shares
CY2018	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	800000	shares
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	100000000	USD
CY2018	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	100000000	USD
CY2018Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	5100000	USD
CY2016	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
CY2017	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
CY2018	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	36000000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	15600000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	39800000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	22800000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	25900000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	14900000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	300000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	0	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	32600000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3300000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3400000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	8400000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	66600000	USD
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	7800000	USD
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	12400000	USD
CY2017Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	11400000	USD
CY2018Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	7200000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	9500000	USD
CY2017	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	5300000	USD
CY2018	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	3600000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Recoveries ValuationAllowancesAndReservesRecoveries	700000	USD
CY2017	us-gaap	Valuation Allowances And Reserves Recoveries ValuationAllowancesAndReservesRecoveries	700000	USD
CY2018	us-gaap	Valuation Allowances And Reserves Recoveries ValuationAllowancesAndReservesRecoveries	500000	USD
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	83600000	shares
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	86300000	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	88200000	shares
CY2018	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term investment securities, and accounts receivable. We limit our exposure to credit loss by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position. </font></div></div>
CY2018	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Organization and Business</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom, Inc. is a medical device company focused on the design, development and commercialization of</font><font style="font-family:inherit;font-size:10pt;"> continuous glucose monitoring, or CGM,</font><font style="font-family:inherit;font-size:10pt;"> systems for ambulatory use by people with diabetes and by healthcare providers. Unless the context requires otherwise, the terms “we,” “us,” “our,” the “company,” or “DexCom” refer to DexCom, Inc. and its subsidiaries.</font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font></div></div>
CY2018	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include pharmacy rebates, transaction price, net accounts receivable, excess or obsolete inventories and the valuation of inventory, and accruals for litigation contingencies. </font></div></div>

Files In Submission

Name	View Source	Status
0001093557-19-000041-index-headers.html	Edgar Link	pending
0001093557-19-000041-index.html	Edgar Link	pending
0001093557-19-000041.txt	Edgar Link	pending
0001093557-19-000041-xbrl.zip	Edgar Link	pending
dxcm-12312018x10k.htm	Edgar Link	pending
dxcm-20181231.xml	Edgar Link	completed
dxcm-20181231.xsd	Edgar Link	pending
dxcm-20181231_cal.xml	Edgar Link	unprocessable
dxcm-20181231_def.xml	Edgar Link	unprocessable
dxcm-20181231_lab.xml	Edgar Link	unprocessable
dxcm-20181231_pre.xml	Edgar Link	unprocessable
dxcm12312018exhibit1060.htm	Edgar Link	pending
dxcm12312018exhibit1061.htm	Edgar Link	pending
dxcm12312018exhibit2101.htm	Edgar Link	pending
dxcm12312018exhibit2301.htm	Edgar Link	pending
dxcm12312018exhibit3101.htm	Edgar Link	pending
dxcm12312018exhibit3102.htm	Edgar Link	pending
dxcm12312018exhibit3201.htm	Edgar Link	pending
dxcm12312018exhibit3202.htm	Edgar Link	pending
dxcmfiveyearstockgraph2018v2.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
singledaydataa01.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DXCM
DEXCOM INC Stock $dxcm

2018 Q4 Form 10-K Financial Statement

#000109355719000041 Filed on February 21, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DXCM DEXCOM INC Stock $dxcm

2018 Q4 Form 10-K Financial Statement

#000109355719000041 Filed on February 21, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DXCM
DEXCOM INC Stock $dxcm